Literature DB >> 3018261

Mini-F E protein: the carboxy-terminal end is essential for E gene repression and mini-F copy number control.

F Bex, P Piérard, A Desmyter, P Drèze, M Colet, M Couturier.   

Abstract

Mini-F is a segment of the conjugative plasmid F consisting of two origins of replication flanked by regulatory regions, which ensure a normal control of replication and partitioning. Adjacent to the ori-2 origin is a complex coding region that consists of the E gene overlapped by three open reading frames with the coding potential for 9000 Mr polypeptides here designated 9 kd-1, 9 kd-2 and 9 kd-3. In this paper, we show that open reading frame 9 kd-3 is preceded by active promoter and Shine-Dalgarno sequences. The E coding region specifies: an initiator of replication, which acts at the ori-2 site; a function that negatively regulates the expression of the E gene; and a function involved in mini-F copy number control. To assign one of these functions to one of the overlapping coding sequence, we have isolated, characterized and sequenced mutations mapping in the E coding region. In this paper, we analyse two mutations (cop5 and pla25) that abolish the repression of the E gene. As these mutations affect the primary structure of protein E itself but not the 9 kd polypeptides, we conclude that protein E takes part in the negative regulation of its own synthesis. In addition, the localization of the cop5 and pla25 mutations indicates that the carboxy-terminal end of the E protein is involved in the autorepression function. The cop5 mutation causes an eightfold increase of the mini-F copy number. The pla25 mutation leads to the inability of the derived mini-F plasmid to give rise to plasmid-harbouring bacteria. The ways in which the cop5 and pla25 mutations may lead to such phenotypes are discussed in relation to the different functions mapping in the E coding sequence.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3018261     DOI: 10.1016/0022-2836(86)90511-5

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  9 in total

1.  The 41 carboxy-terminal residues of the miniF plasmid CcdA protein are sufficient to antagonize the killer activity of the CcdB protein.

Authors:  P Bernard; M Couturier
Journal:  Mol Gen Genet       Date:  1991-04

Review 2.  Identification and classification of bacterial plasmids.

Authors:  M Couturier; F Bex; P L Bergquist; W K Maas
Journal:  Microbiol Rev       Date:  1988-09

3.  Characterization of the replicon of plasmid pSW500 of Erwinia stewartii.

Authors:  J F Fu; H C Chang; Y M Chen; Y S Chang; S T Liu
Journal:  Mol Gen Genet       Date:  1996-04-10

4.  Involvement of DnaK protein in mini-F plasmid replication: temperature-sensitive seg mutations are located in the dnaK gene.

Authors:  B Ezaki; T Ogura; H Mori; H Niki; S Hiraga
Journal:  Mol Gen Genet       Date:  1989-08

5.  Replication of mini-P1 plasmid DNA in vitro requires two initiation proteins, encoded by the repA gene of phage P1 and the dnaA gene of Escherichia coli.

Authors:  S H Wickner; D K Chattoraj
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

6.  Possible involvement of the ugpA gene product in the stable maintenance of mini-F plasmid in Escherichia coli.

Authors:  B Ezaki; H Mori; T Ogura; S Hiraga
Journal:  Mol Gen Genet       Date:  1990-09

7.  DNA-binding domain of the RepE initiator protein of mini-F plasmid: involvement of the carboxyl-terminal region.

Authors:  F Matsunaga; Y Kawasaki; M Ishiai; K Nishikawa; T Yura; C Wada
Journal:  J Bacteriol       Date:  1995-04       Impact factor: 3.490

Review 8.  Replication of plasmids in gram-negative bacteria.

Authors:  U Kües; U Stahl
Journal:  Microbiol Rev       Date:  1989-12

9.  Mini-F plasmid mutants able to replicate in the absence of sigma 32: mutations in the repE coding region producing hyperactive initiator protein.

Authors:  Y Kawasaki; C Wada; T Yura
Journal:  J Bacteriol       Date:  1991-02       Impact factor: 3.490

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.